Fig. 4From: Gastrointestinal stromal tumors treated at a Brazilian Cancer Center: evaluation of clinical, epidemiological, and therapeutic profilesPositron emission tomography-computed tomography (PET-CT) FDG: Pre (a) and post (b) Imatinib therapy. The abdominal mass presents decrease in FDG uptake inferring good response even without significant change in sizeBack to article page